HCA Healthcare (HCA) to Release Quarterly Earnings on Tuesday

HCA Healthcare (NYSE:HCA) is set to post its quarterly earnings results before the market opens on Tuesday, July 23rd. Analysts expect HCA Healthcare to post earnings of $4.91 per share for the quarter. HCA Healthcare has set its FY 2024 guidance at 19.700-21.200 EPS and its FY24 guidance at $19.70-21.20 EPS.Investors that are interested in registering for the company’s conference call can do so using this link.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. The business had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company’s revenue was up 11.2% on a year-over-year basis. During the same period in the previous year, the firm posted $4.93 earnings per share. On average, analysts expect HCA Healthcare to post $21 EPS for the current fiscal year and $23 EPS for the next fiscal year.

HCA Healthcare Stock Performance

NYSE HCA opened at $322.16 on Monday. The company has a market cap of $84.38 billion, a P/E ratio of 16.06, a P/E/G ratio of 1.46 and a beta of 1.68. HCA Healthcare has a 1-year low of $215.96 and a 1-year high of $344.20. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. The stock has a 50-day moving average of $327.99 and a two-hundred day moving average of $321.72.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 14th were given a $0.66 dividend. The ex-dividend date of this dividend was Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.82%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on HCA shares. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Barclays upped their target price on shares of HCA Healthcare from $367.00 to $376.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 10th. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a research report on Tuesday, July 9th. Finally, Robert W. Baird initiated coverage on HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $327.06.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction on Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the sale, the executive vice president now owns 34,124 shares in the company, valued at approximately $10,544,316. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the sale, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 6,311 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the sale, the executive vice president now owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 12,397 shares of company stock worth $3,921,929. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.